Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Pivotal Trial of Autologous Bone Marrow Cells Using the CardiAMP Cell Therapy System in Patients With Refractory Angina Pectoris and Chronic Myocardial Ischemia (CardiAMP CMI Trial)

NCT03455725 is registered in ClinicalTrials.gov with BioCardia, Inc. as lead sponsor.

NCT NCT03455725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03455725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Cells Using the CardiAMP Cell Therapy System in Patients With Refractory Angina Pectoris and Chronic Myocardial Ischemia (CardiAMP CMI Trial)
Lead sponsor
BioCardia, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 30, 2021
Completion date
December 31, 2027
Enrollment
343 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myocardial ischemia, refractory angina